157 results on '"Engler,Tobias"'
Search Results
2. Aberrant p53 immunostaining patterns in breast carcinoma of no special type strongly correlate with presence and type of TP53 mutations
3. Association between 21-gene-assay and detection of disseminated tumor cells in patients with early breast cancer: results from the IRMA trial
4. Detection of circulating cell-free HPV DNA of 13 HPV types for patients with cervical cancer as potential biomarker to monitor therapy response and to detect relapse
5. Certification as dysplasia unit and its impact on large loop electrosurgical excision (LEEP)
6. Demand-oriented design of telemedical services in gynecologic oncology
7. Machine learning and patient-reported outcomes for longitudinal monitoring of disease progression in metastatic breast cancer: a multicenter, retrospective analysis
8. Characterization and clinical management of abnormal cytology findings in pregnant women: a retrospective analysis
9. Comparing the HER2 Status of the Primary Tumor to That of Disseminated Tumor Cells in Early Breast Cancer
10. Vergleich von Trastuzumab-Biosimilar ABP 980 mit Referenz-Trastuzumab bei der neoadjuvanten Therapie von HER2-positivem Brustkrebs – Analyse eines großen universitären Brustkrebszentrums
11. Implementation and Evaluation of a Breast Cancer Disease Model Using Real-World Claims Data in Germany from 2010 to 2020
12. Platelet-expressed immune checkpoint regulator GITRL in breast cancer
13. Novel Antibody-Drug-Conjugates in Routine Clinical Practice for the Treatment of Metastatic Breast Cancer: Adherence, Efficacy and Tolerability – Real-World Data from German Breast Centers.
14. ENABLE: App-based digital capture and intervention of patientreported quality of life, adverse events, and treatment satisfaction in breast cancer - study protocol for a randomized controlled trial
15. ENABLE – eine digitale therapiebegleitende Plattform für Patientinnen mit invasivem Mammakarzinom.
16. Soluble NKG2DLs Are Elevated in Breast Cancer Patients and Associate with Disease Outcome.
17. The Clinical Relevance of the NATALEE Study: Application of the NATALEE Criteria to a Real-World Cohort from Two Large German Breast Cancer Centers
18. Die CAPTOR-BC-Studie.
19. The immunopeptidomic landscape of ovarian carcinomas
20. Microfluidic Isolation of Disseminated Tumor Cells from the Bone Marrow of Breast Cancer Patients
21. Targeting NKG2DL with Bispecific NKG2D–CD16 and NKG2D–CD3 Fusion Proteins on Triple–Negative Breast Cancer
22. Tumor-Free Resection Margin Distance in the Surgical Treatment of Node-Negative Squamous Cell Cancer of the Vulva Has No Impact on Survival: Analysis of a Large Patient Cohort in a Tertiary Care Center
23. Which Patients Do We Need to Test for BRCA1/2 Mutation? Feasibility of Adjuvant Olaparib Treatment in Early Breast Cancer–Real-World Data from Two Large German Breast Centers
24. Influence of [18F]FDG-PET/CT on Clinical Management Decisions in Breast Cancer Patients—A PET/CT Registry Study
25. Advancing Cancer Therapy Predictions with Patient-Derived Organoid Models of Metastatic Breast Cancer
26. Moderne Therapie des Mammakarzinoms und gynäkologischer Tumoren: Nebenwirkungen erkennen und beherrschen
27. Detection of Disseminated Tumor Cells in Patients with Early Breast Cancer is Associated with 21-Gene-Assay: Results from the Impact of Recurrence Score ® Result on Adjuvant Treatment Decisions and Tumor Cell Dissemination in Estrogen Receptor-Positive and HER2-Negative Patients with Early Breast Cancer (IRMA) Trial
28. Abstract 4376: A correlation of soluble HLA serum levels with clinical data and survival in patients with invasive breast cancer after neoadjuvant treatment
29. Einführung von CDK4/6-Hemmern und deren Auswirkung auf die Behandlungslandschaft bei Patientinnen mit Brustkrebs im fortgeschrittenen Stadium – Real-World-Daten aus dem PRAEGNANT-Register
30. Clinical outcome of biomarker-guided therapies in adult patients with tumors of the nervous system
31. Understanding online product ratings: A customer satisfaction model
32. Influence of social software features on the reuse of Business Intelligence reports
33. Comparison of Biosimilar Trastuzumab ABP 980 with Reference Trastuzumab in Neoadjuvant Therapy for HER2-positive Breast Cancer – an Analysis of a Large University Breast Cancer Centre
34. O032/#771 Circulating HPV cell-free DNA in cervical cancer
35. Recurrence Score® Result Impacts Treatment Decisions in Hormone Receptor-Positive, HER2-Negative Patients with Early Breast Cancer in a Real-World Setting—Results of the IRMA Trial
36. Certification as dysplasia unit and its impact on large loop electrosurgical excision (LEEP)
37. 2022-RA-1048-ESGO Circulating HPV cell-free DNA in cervical cancer
38. Finding Information Faster by Tracing My Colleagues' Trails
39. Influence of [ 18 F]FDG-PET/CT on Clinical Management Decisions in Breast Cancer Patients—A PET/CT Registry Study.
40. Implementation of CDK4/6 Inhibitors and its Influence on the Treatment Landscape of Advanced Breast Cancer Patients – Data from the Real-World Registry PRAEGNANT
41. Comparison of Biosimilar Trastuzumab ABP 980 with Reference Trastuzumab in Neoadjuvant Therapy for HER2-positive Breast Cancer – an Analysis of a Large University Breast Cancer Centre.
42. Characterization and Clinical Management of Abnormal Cytology Findings in Pregnant Women - A Retrospective Analysis
43. Feasibility of adjuvant treatment with abemaciclib—real-world data from a large german breast center
44. Feasibility of Adjuvant Treatment with Abemaciclib—Real-World Data from a Large German Breast Center
45. Implementation of an Electronic Patient-Reported Outcome App for Health-Related Quality of Life in Breast Cancer Patients: Evaluation and Acceptability Analysis in a Two-Center Prospective Trial
46. Neoadjuvant Chemotherapy of Patients with Early Breast Cancer Is Associated with Increased Detection of Disseminated Tumor Cells in the Bone Marrow
47. Design of interactive augmented reality functions for robotic surgery and evaluation in dry‐lab lymphadenectomy
48. Measuring the Time to Deterioration for Health-Related Quality of Life in Patients With Metastatic Breast Cancer Using a Web-Based Monitoring Application: Longitudinal Cohort Study
49. Recurrence Score ® Result Impacts Treatment Decisions in Hormone Receptor-Positive, HER2-Negative Patients with Early Breast Cancer in a Real-World Setting—Results of the IRMA Trial.
50. HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.